DBD | Diebold Nixdorf, IncorporatedNYSETechnologyCommon stock golden cross and death cross projections, cross tests and history

$55.82
-$0.23 (-0.41%)

Diebold Nixdorf, Incorporated (DBD) is a NYSE-listed common stock that Cruxta has tracked for 50/200 crosses since 2025.

The 50 SMA has sat below the 200 on the daily since Sep 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits below the 50 and the 200 on the daily and the 4-hour.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
below both $55.82 vs 50 $64.62 / 200 $74.82
Projection
No cross projected
Test
No active test
Last cross
Death cross 15 Sep 2026 ยท projected 27 bars out

Weekly

No weekly data

4-hour as of 3 Nov 13:30 ET

Price
below both $57.00 vs 50 $63.99 / 200 $72.54
Projection
No cross projected
Test
No active test
Last cross
Death cross 14 Aug 2026 ยท projected 26 bars out

Cross history

8
crosses on record since 2025
3 golden5 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
15 Sep 2026Death steepdaily27 bars outNot tested
14 Aug 2026Death4-hour26 bars outNot tested
10 Nov 2025Golden4-hour9 bars outNot tested
22 Oct 2025Death4-hour15 bars out2 bar cross test
16 May 2025Golden moderatedaily9 bars outNot tested

About DBD

ExchangeNYSE
InstrumentCommon stock
Median $ volume, 60 d$14.6M
4-hour coverageYes, since Oct 2025
History on recordSince 2025
SectorTechnology
Cap bandmid

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.